Stay updated on Talazoparib in DNA Repair Defects Clinical Trial
Sign up to get notified when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.

Latest updates to the Talazoparib in DNA Repair Defects Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRecruitment status changed to Completed with 'No longer looking for participants,' indicating enrollment has ended. New help/navigation sections were added to guide users, while some headers and related topics were reformatted or removed to streamline the page.SummaryDifference0.3%

- Check21 days agoChange DetectedThe page now includes a Prostate cancer tag and related topics (MedlinePlus Genetics); the revision is updated to v3.5.5.SummaryDifference0.1%

- Check28 days agoChange DetectedProstate cancer labeling and the related topics reference (MedlinePlus Genetics) were removed from the page. This changes how the study's disease context and connections to related resources are presented.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page now lists Prostate cancer as a related topic and adds MedlinePlus Genetics under related topics, expanding cross-reference information for readers.SummaryDifference0.1%

- Check42 days agoChange DetectedA new Lancet Oncology TALAPRO-1 citation was added to the Publications section. The earlier Lancet Oncology entry, including its erratum, was removed.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page’s footer revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change to the ClinicalTrials.gov site UI rather than any study information.SummaryDifference0.0%

Stay in the know with updates to Talazoparib in DNA Repair Defects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.